151 related articles for article (PubMed ID: 20622759)
1. Prevalence of bone loss in a population with cystic fibrosis.
Robertson J; Macdonald K
Br J Nurs; 2010 May 27-Jun 9; 19(10):636-9. PubMed ID: 20622759
[TBL] [Abstract][Full Text] [Related]
2. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
Shane E; Silverberg SJ; Donovan D; Papadopoulos A; Staron RB; Addesso V; Jorgesen B; McGregor C; Schulman L
Am J Med; 1996 Sep; 101(3):262-9. PubMed ID: 8873487
[TBL] [Abstract][Full Text] [Related]
3. Oral bisphosphonates improve Bone Mineral Density in adults with cystic fibrosis.
Cawood TJ; McKenna MJ; Gallagher CG; Smith D; Wen YC; Gibney J; Dodd JD; O'Shea D
Ir Med J; 2005 Oct; 98(9):270-3. PubMed ID: 16300106
[TBL] [Abstract][Full Text] [Related]
4. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy--antiepileptic drug and osteoporosis prevention trial.
Lazzari AA; Dussault PM; Thakore-James M; Gagnon D; Baker E; Davis SA; Houranieh AM
Epilepsia; 2013 Nov; 54(11):1997-2004. PubMed ID: 24010637
[TBL] [Abstract][Full Text] [Related]
5. Bisphosphonates for osteoporosis in people with cystic fibrosis.
Conwell LS; Chang AB
Cochrane Database Syst Rev; 2009 Oct; (4):CD002010. PubMed ID: 19821288
[TBL] [Abstract][Full Text] [Related]
6. Intravenous zoledronate improves bone density in adults with cystic fibrosis (CF).
Chapman I; Greville H; Ebeling PR; King SJ; Kotsimbos T; Nugent P; Player R; Topliss DJ; Warner J; Wilson JW
Clin Endocrinol (Oxf); 2009 Jun; 70(6):838-46. PubMed ID: 18823395
[TBL] [Abstract][Full Text] [Related]
7. Role of exercise and nutrition status on bone mineral density in cystic fibrosis.
Frangolias DD; Paré PD; Kendler DL; Davidson AG; Wong L; Raboud J; Wilcox PG
J Cyst Fibros; 2003 Dec; 2(4):163-70. PubMed ID: 15463868
[TBL] [Abstract][Full Text] [Related]
8. Increased whole body hydroxyproline production as assessed by a new stable isotope technique is associated with hip and spine bone mineral loss in cystic fibrosis.
Engelen MP; Com G; Deutz NE
Clin Nutr; 2014 Dec; 33(6):1117-21. PubMed ID: 24423745
[TBL] [Abstract][Full Text] [Related]
9. Risks of osteoporosis associated with breast cancer treatment: the need to access to preventive treatment.
Rozenberg S; Carly B; Liebens F; Antoine C
Maturitas; 2009 Sep; 64(1):1-3. PubMed ID: 19709824
[TBL] [Abstract][Full Text] [Related]
10. Effect of oral bisphosphonates on bone mineral density and body composition in adult patients with cystic fibrosis: a pilot study.
Conway SP; Oldroyd B; Morton A; Truscott JG; Peckham DG
Thorax; 2004 Aug; 59(8):699-703. PubMed ID: 15282392
[TBL] [Abstract][Full Text] [Related]
11. High prevalence of early-onset osteopenia/osteoporosis after allogeneic stem cell transplantation and improvement after bisphosphonate therapy.
Yao S; McCarthy PL; Dunford LM; Roy DM; Brown K; Paplham P; Syta M; Lamonica D; Smiley S; Battiwalla M; Padmanabhan S; Hahn T
Bone Marrow Transplant; 2008 Feb; 41(4):393-8. PubMed ID: 17994116
[TBL] [Abstract][Full Text] [Related]
12. [Measurement of bone mineral density is unnecessary for monitoring of bisphosphonate treatment].
Nishida A; Ito M
Clin Calcium; 2011 Jan; 21(1):120-3. PubMed ID: 21187605
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of low bone mass and vitamin D deficiency in pediatric and adult patients with cystic fibrosis in Republic of Macedonia.
Jakovska T; Mecevska-Jovcevska J; Petlickovski A; Fustik S; Zorcec T
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2014; 35(1):151-8. PubMed ID: 24802200
[TBL] [Abstract][Full Text] [Related]
14. Osteoporosis in Canadian adult cystic fibrosis patients: a descriptive study.
Brenckmann C; Papaioannou A; Freitag A; Hennessey R; Hansen S; Ioannidis G; Webber C; Adachi J
BMC Musculoskelet Disord; 2003 Jun; 4():13. PubMed ID: 12823863
[TBL] [Abstract][Full Text] [Related]
15. Management of osteoporosis in adults with cystic fibrosis.
Hecker TM; Aris RM
Drugs; 2004; 64(2):133-47. PubMed ID: 14717616
[TBL] [Abstract][Full Text] [Related]
16. Guidance for the management of breast cancer treatment-induced bone loss: a consensus position statement from a UK Expert Group.
Reid DM; Doughty J; Eastell R; Heys SD; Howell A; McCloskey EV; Powles T; Selby P; Coleman RE
Cancer Treat Rev; 2008; 34 Suppl 1():S3-18. PubMed ID: 18515009
[TBL] [Abstract][Full Text] [Related]
17. Bone mineral density in cystic fibrosis patients under the age of 18 years.
Neri AS; Lori I; Festini F; Masi L; Brandi ML; Galici V; Braggion C; Taccetti G
Minerva Pediatr; 2008 Apr; 60(2):147-54. PubMed ID: 18449130
[TBL] [Abstract][Full Text] [Related]
18. Osteoporosis risk in premenopausal women.
Vondracek SF; Hansen LB; McDermott MT
Pharmacotherapy; 2009 Mar; 29(3):305-17. PubMed ID: 19249949
[TBL] [Abstract][Full Text] [Related]
19. Reduced bone density in cystic fibrosis: DeltaF508 mutation is an independent risk factor.
King SJ; Topliss DJ; Kotsimbos T; Nyulasi IB; Bailey M; Ebeling PR; Wilson JW
Eur Respir J; 2005 Jan; 25(1):54-61. PubMed ID: 15640323
[TBL] [Abstract][Full Text] [Related]
20. Antiepileptic drugs and high prevalence of low bone mineral density in a group of inpatients with chronic epilepsy.
Beerhorst K; Tan IY; De Krom M; Verschuure P; Aldenkamp AP
Acta Neurol Scand; 2013 Oct; 128(4):273-80. PubMed ID: 23461582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
